The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Over 8.8?million Indians aged 60 and above currently live with dementia,
Blood tests measuring biomarkers such as p-tau217 are emerging as accurate, accessible alternatives
The company is excluding data from the affected sites to maintain the study's integrity
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging
Subscribe To Our Newsletter & Stay Updated
